Related Experiment Video
Updated: Jul 21, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
TP53BP2: Roles in suppressing tumorigenesis and therapeutic opportunities
Yunfei Huo1, Ke Cao1, Buxin Kou1
1Beijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
Abstract:
Malignant tumor is still a major problem worldwide. During tumorigenesis or tumor development, tumor suppressor p53-binding protein 2 (TP53BP2), also known as apoptosis stimulating protein 2 of p53 (ASPP2), plays a critical role in p53 dependent and independent manner. Expression of TP53BP2 is highly correlated with the prognosis and survival rate of malignant tumor patients. TP53BP2 can interact with p53, NF-κB p65, Bcl-2, HCV core protein, PP1, YAP, CagA, RAS, PAR3, and other proteins to regulate cell function. Moreover, TP53BP2 can also regulate the proliferation, apoptosis, autophagy, migration, EMT and drug resistance of tumor cells through downstream signaling pathways, such as NF-κB, RAS/MAPK, mevalonate, TGF-β1, PI3K/AKT, aPKC-ι/GLI1 and autophagy pathways. As a potential therapeutic target, TP53BP2 has been attracted more attention. We review the role of TP53BP2 in tumorigenesis or tumor development and the signal pathway involved in TP53BP2, which may provide more deep insight and strategies for tumor treatment.
Insights
Apoptosis stimulating protein 2 of p53 (ASPP2) is crucial in tumor development and impacts patient survival. Targeting ASPP2 offers potential new strategies for treating malignant tumors.
Area of Science:
- Oncology
- Molecular Biology
- Cellular Biology
Background:
- Malignant tumors pose a significant global health challenge.
- Tumor suppressor p53-binding protein 2 (TP53BP2), also known as apoptosis stimulating protein 2 of p53 (ASPP2), is vital in tumorigenesis.
- TP53BP2 expression correlates with patient prognosis and survival rates in malignant tumors.
Purpose of the Study:
- To review the multifaceted role of TP53BP2 in tumor development.
- To elucidate the signaling pathways regulated by TP53BP2.
- To highlight TP53BP2 as a potential therapeutic target for cancer treatment.
Main Methods:
- Literature review of studies on TP53BP2 function in tumorigenesis.
- Analysis of TP53BP2 interactions with key proteins (e.g., p53, NF-κB p65, YAP).
- Examination of TP53BP2's regulation of cellular processes (proliferation, apoptosis, migration, EMT, drug resistance) via signaling pathways.
Main Results:
- TP53BP2 interacts with numerous proteins to modulate cellular functions.
- TP53BP2 influences critical cancer hallmarks including proliferation, apoptosis, migration, EMT, and drug resistance.
- TP53BP2 regulates downstream pathways such as NF-κB, RAS/MAPK, and PI3K/AKT.
Conclusions:
- TP53BP2 plays a critical role in both p53-dependent and independent pathways during tumorigenesis.
- Understanding TP53BP2's regulatory network provides insights into cancer progression.
- TP53BP2 represents a promising therapeutic target for developing novel anti-cancer strategies.
Related Concept Videos
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Negative Regulator Molecules
Targeted Cancer Therapies
There are several types of targeted therapies against...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

